New Alzhiemer's medicine being tested in Abington

ABINGTON, Pa. (WPVI) -- A new medicine for Alzheimer's is being tested in Montgomery County.

Abington Neurological Associates is evaluating T-817MA for mild to moderate Alzheimer's.

Current drugs boost neuro-transmitters - the brain's chemical messengers.

While they improve memory a little, the disease itself continues to progress.

T-817MA is designed to slow the disease down and protect nerve cells in the brain.

"They slowly spread out and involve speech and language and visual-spatial areas. What this medication is designed to do is prevent that toxicity, and protect the nerve cells from getting destroyed," said Dr. David Weisman.

The study is open to volunteers.

For more information, call Abington Neurological Associates at 215-957-9250 - ext. 6, and on the NOBLE study, see www.noblestudy.org.